W 922 (Cefuroxime 500 mg)
Pill imprint W 922 has been identified as Cefuroxime axetil 500 mg.
Cefuroxime is used in the treatment of sinusitis; urinary tract infection; bacterial infection; bronchitis; bladder infection (and more), and belongs to the drug class second generation cephalosporins. There is no proven risk in humans during pregnancy. Cefuroxime 500 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for W 922 (Cefuroxime 500 mg)
- Imprint:
-
W 922
- Strength:
- 500 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Second generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Wockhardt USA
- National Drug Code (NDC):
- 64679-0922
| NDC Code | Manufacturer / Repackager |
|---|---|
| 58016-0964 | Southwood Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
More resources
Cefuroxime axetil is associated with the treatment of:
- Bacterial Infection
- Bladder Infection
- Bone infection
- Bronchitis
- Epiglottitis
- Gonococcal Infection, Disseminated
- Gonococcal Infection, Uncomplicated
- Impetigo
- Joint Infection
- Kidney Infections
- Lyme Disease
- Meningitis
- Otitis Media
- Peritonitis
- Pneumonia
- Sepsis
- Sinusitis
- Skin and Structure Infection
- Skin Infection
- Strep Throat
- Surgical Prophylaxis
- Tonsillitis/Pharyngitis
- Upper Respiratory Tract Infection
- Urinary Tract Infection
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
